We discuss a COVID-19 vaccine's journey from testing to public distribution.

From Testing To Distribution: The Logistics Behind COVID-19 Vaccines

Anna Bauman

Producer/Director, On Point

Meghna Chakrabarti

Host, On Point

Scientists work at the mAbxience biosimilar monoclonal antibody laboratory plant in Garin, Buenos Aires province, on August 14, 2020, where an experimental coronavirus vaccine will be produced for Latin America. - Argentina will manufacture while Mexico will pack and distribute in Latin America, except of Brazil, the vaccine against COVID-19 developed by the University of Oxford and the AstraZeneca laboratory. (Juan Mabromata/AFP via Getty Images)

ARGENTINA-HEALTH-VIRUS-VACCINE-LABORATORY

Early data shows that two COVID-19 vaccines are over 90% effective. So what’s next? Dr. Jennifer Dillaha, Julie Swann and William Schaffner join Meghna Chakrabarti to explain the vaccine’s journey from testing to public distribution.

On Point's Coronavirus Hours

Coronavirus Vaccine Coverage

podcast

Health

Science

How do you quickly develop a safe, effective vaccine in the middle of a historic global pandemic? We ask researchers who are trying to do just that.

The Race To Develop A Coronavirus Vaccine

Brittany Knotts

Freelance Producer

Three potential coronavirus, COVID-19, vaccines are kept in a tray at Novavax labs in Rockville, Maryland on March 20, 2020, one of the labs developing a vaccine for the coronavirus, COVID-19. (ANDREW CABALLERO-REYNOLDS/AFP via Getty Images)

How do you quickly develop a safe, effective vaccine in the middle of a historic global pandemic? We ask researchers who are trying to do just that. Dr. Dan Barouch and Natalie Dean join Meghna Chakrabarti.